A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults

Clinical trial NCT07226362 · COMPLETED

Trial details

NCT number: NCT07226362
Sponsor: Aspeya Switzerland SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety, and Tolerability

Start date: 2025-06-09
Primary completion: 2025-10-02
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.